Debt Investors
Capital allocation principles
董事会的目标是继续在企业的利益之间取得平衡, 财务债权人和公司股东. 公司的资本配置重点包括投资于业务和管道, maintaining a strong, investment-grade credit rating, 潜在的增值业务发展机会, 支持累进派息政策. 董事会打算维持累进派息政策, 平衡发展机会和适当的保险水平.
Funding strategy
- 董事会每年审查公司持续的流动性风险,作为规划过程的一部分,并在临时基础上进行审查.
- 委员会根据现有资金来源审议短期所需经费, 考虑到预期的现金流.
- 本公司通过保持大量资金来源来管理流动性风险,这些资金来源足以满足预期的资金需求.
- Specifically, 公司使用美国商业票据及/或欧洲商业票据方案, 承诺银行设施和现金资源以管理短期流动性.
- 该公司通过既定的欧元中期票据(EMTN)计划和美国证券交易委员会(SEC)注册的货架计划,保持强有力的资本市场长期融资渠道.
- 本公司亦可获得本集团关系银行提供的定期贷款. At 31 December 2022, 用于收购Alexion Pharmaceutical的40亿美元贷款尚未偿还, Inc..
- The Company has $4.13家关系银行提供了90亿美元的循环承诺信贷安排. 这些设施已于2022年12月31日提取,并将于2026年4月到期. 2023年2月2日,集团获得额外20亿美元的两年承诺银行贷款.
- 这些不同的融资计划确保公司在选择期限时有足够的灵活性, currency, interest rate (fixed/floating), and geographical mix of investors.
Programme | Last updated | Valid to | Limit | Rating (Moody's/ S&P) | Utilisation as at 30 September 2022 |
---|---|---|---|---|---|
US Commercial Paper |
N/A |
N/A |
USD 15bn |
A-1 / P-2 |
None |
Euro-Commercial Paper |
12 May 2020 |
N/A |
EUR 10bn |
Issuer rating |
None |
June 2022 |
June 2023 |
USD 10bn |
A3 / A |
USD 3.1bn |
|
SEC Shelf Registration Statement |
May 2021 |
May 2024 |
Unlimited |
A3 / A |
USD 20.5bn |
Debt maturity profile
im体育选择持有大量现金余额以满足运营资金需求. 截至2022年12月31日,现金和投资总额为6美元.4bn
1 Notional bond values. 按2022年12月31日即期汇率(美元/欧元0.939; USD/GBP 0.829). 目前2.28亿美元的租赁部分包括在2023年, 而7.25亿美元的非流动租赁则被排除在图表之外.
Outstanding bonds
以下是截至2022年12月31日im体育公司发行或担保的债券摘要, sorted by maturity date.
Currency | Notional (m) | Issue date | Maturity date | Coupon | Frequency | ISIN |
USD | 1,400 | 28-May-21 | 26-May-23 | 0.300% | Semi-annual | US046353AY48 |
USD | 850 | 17-Aug-18 | 17-Aug-23 | 3.500% | Semi-annual | US046353AR96 |
USD | 400 | 17-Aug-18 | 17-Aug-23 | 3m Libor + 0.665% | Quarterly | US046353AS79 |
USD | 287 | 15-Nov-93 | 15-Nov-23 | 7.000% | Semi-annual | US98934KAB61 |
EUR | 900 | 12-May-16 | 12-May-24 | 0.750% | Annual | XS1411404855 |
USD | 1,600 | 28-May-21 | 28-May-24 | 0.700% | Semi-annual | US04636NAC74 |
USD | 2,000 | 16-Nov-15 | 16-Nov-25 | 3.375% | Semi-annual | US046353AL27 |
USD | 1,200 | 6-Aug-20 | 8-Apr-26 | 0.700% | Semi-annual | US046353AV09 |
USD | 1,250 | 28-May-21 | 28-May-26 | 1.200% | Semi-annual | US04636NAA19 |
USD | 750 | 12-Jun-17 | 12-Jun-27 | 3.125% | Semi-annual | US046353AN82 |
EUR | 800 | 12-May-16 | 12-May-28 | 1.250% | Annual | XS1411404426 |
USD | 1,250 | 28-May-21 | 28-May-28 | 1.750% | Semi-annual | US04636NAE31 |
USD | 1,000 | 17-Aug-18 | 17-Jan-29 | 4.000% | Semi-annual | US046353AT52 |
EUR | 800 | 3-Jun-21 | 3-Jun-29 | 0.375% | Annual | XS2347663507 |
USD | 1,300 | 6-Aug-20 | 6-Aug-30 | 1.375% | Semi-annual | US046353AW81 |
USD | 750 | 28-May-21 | 28-May-31 | 2.250% | Semi-annual | US04636NAB91 |
GBP | 350 | 13-Nov-07 | 13-Nov-31 | 5.750% | Annual | XS0330497149 |
USD | 2,750 | 12-Sep-07 | 15-Sep-37 | 6.450% | Semi-annual | US046353AD01 |
USD | 1,000 | 18-Sep-12 | 18-Sep-42 | 4.000% | Semi-annual | US046353AG32 |
USD | 1,000 | 16-Nov-15 | 16-Nov-45 | 4.375% | Semi-annual | US046353AM00 |
USD | 750 | 17-Aug-18 | 17-Aug-48 | 4.375% | Semi-annual | US046353AU26 |
USD | 500 | 6-Aug-20 | 6-Aug-50 | 2.125% | Semi-annual | US046353AX64 |
USD | 750 | 25-May-21 | 28-May-51 | 3.000% | Semi-annual | US046353AZ13 |
Credit ratings
im体育公司(AstraZeneca PLC)的目标是保持强劲的投资级信用评级. 公司已向穆迪和S . S .征求信用评级&P, which are assigned as:
Moody's |
S&P | |
---|---|---|
Short-term rating | P-2 | A-1 |
Long-term rating | A3 | A |
Outlook | Stable | Stable |
有关机构的主要联络人是:
Moody’s
Analyst: Frederic Duranson
Phone: +44-20-7772-1950
S&P
Analyst: Paulina Grabowiec
Phone: +44 207 176 7051
Treasury risk management policies
本公司以集中的财务结构运作,以便在集团层面管理关键的财务风险.
Liquidity Policy
- 可用现金和未使用信贷安排的审慎水平
- Group funding centrally managed
Investment policy
- Security and liquidity
- Financial counterparty limits
Foreign Exchange Policy
- 外汇风险集中管理
- 交易性货币风险被大幅对冲
Interest Rate Policy
- 目标是在一段时间内将浮动利率债务与现金水平大致匹配
- 相当一部分固定利率的金融负债
Credit Risk
- Cash managed centrally
- 衍生品头寸完全抵押
Debt IR presentations
Press Releases
2 June 2021 – 07:00
27 May 2021 – 07:00
26 May 2021 – 07:00
04 August 2020 - 07:00
FMSB Statement of Commitment
Contact Us
Christer Gruvris
Director of Investor Relations
Jonathan Slade
Group Treasurer